Abstract 3193: Treatment of high Trop-2-expressing triple-negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51Thomas M. Cardillo, David M. Goldenberg, Diane L. Rossi et al.|Cancer Research|2017Cited by 8